Warp Drive Bio to Present at Cowen and Company 38th Annual Health Care Conference

CAMBRIDGE, Mass.--()--Warp Drive Bio, Inc., a drug discovery company developing therapeutics that exploit the molecules and mechanisms of nature, today announced that Laurence Reid, Ph.D., president and chief executive officer of Warp Drive Bio, will present at the Cowen and Company 38th Annual Health Care Conference on Wednesday, March 14, 2018 at 12:00 p.m. ET at the Boston Marriott Copley Place.

About Warp Drive Bio

Warp Drive Bio is exploiting the molecules and mechanisms of nature to create transformative medicines. The company operates on the core principle that nature is the world’s most powerful inventor of new drugs, unconstrained by the mechanistic and synthetic limitations of traditional medicinal chemistry. Warp Drive Bio is deploying its proprietary Genome Mining™ and SMART™ (Small Molecule Assisted Receptor Targeting) platforms to discover novel medicines that have the potential to make a significant difference in patients’ lives. For more information, please visit www.warpdrivebio.com.

Contacts

Pure Communications, Inc.
Katie Engleman, 910-509-3977
kengleman@purecommunications.com

Contacts

Pure Communications, Inc.
Katie Engleman, 910-509-3977
kengleman@purecommunications.com